Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 48,926 | 37,647 | 55,198 | 47,830 | 43,660 |
| Cost of Goods | 17,910 | 18,681 | 16,589 | 14,907 | 13,221 |
| Gross Profit | 31,016 | 18,966 | 38,609 | 32,923 | 30,439 |
| Operating Expenses | 79,744 | 76,840 | 78,384 | 79,261 | 83,162 |
| Operating Income | -47,818 | -57,193 | -39,186 | -45,431 | -52,502 |
| Interest Expense | 3,605 | 3,531 | 3,585 | 653 | 0 |
| Other Income | 3,612 | 3,024 | 2,602 | 765 | 418 |
| Pre-tax Income | -47,811 | -57,700 | -40,169 | -45,319 | -52,084 |
| Net Income Continuous | -47,811 | -57,700 | -40,169 | -45,319 | -52,084 |
| Minority Interests | -1 | -1 | -41 | -38 | -38 |
| Net Income | $-47,810 | $-57,699 | $-40,128 | $-45,281 | $-52,046 |
| EPS Basic Total Ops | -0.33 | -0.40 | -0.27 | -0.32 | -0.37 |
| EPS Basic Continuous Ops | -0.33 | -0.40 | -0.28 | -0.32 | -0.37 |
| EPS Diluted Total Ops | -0.33 | -0.40 | -0.27 | -0.32 | -0.37 |
| EPS Diluted Continuous Ops | -0.33 | -0.40 | -0.28 | -0.32 | -0.37 |
| EPS Diluted Before Non-Recurring Items | -0.33 | -0.40 | -0.28 | N/A | N/A |
| EBITDA(a) | $-44,083 | $-53,379 | $-34,984 | $-39,637 | $-46,755 |